Citadel Advisors’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$16K Buy
2022
Q3
Sell
2022
Q2
$226K Buy
2022
Q1
$214K Buy
2021
Q4
$351K Buy
2021
Q3
Sell
2021
Q2
$268K Sell
2021
Q1
$382K Buy
2020
Q4
$274K Buy
2020
Q2
Sell
2020
Q1
$38K Buy